trending Market Intelligence /marketintelligence/en/news-insights/trending/v82Dv0KlNu-IuMeKxY7nLA2 content esgSubNav
Log in to other products

Login to Market Intelligence Platform

 /


Looking for more?

Contact Us
In This List

Aevi Genomic Medicine completes $28M private placement

COVID-19 Pandemic Likely To Cause US Telemedicine Boom

Gauging Supply Chain Risk In Volatile Times

S&P Global Market Intelligence

Cannabis: Hashing Out a Budding Industry

Segment

IFRS 9 Impairment How It Impacts Your Corporation And How We Can Help


Aevi Genomic Medicine completes $28M private placement

Aevi Genomic Medicine Inc. completed its private placement of common shares and warrants for proceeds of $28 million, before expenses.

The Children's Hospital of Philadelphia Foundation was the lead investor.

Aevi Genomic plans to use net proceeds for the development of its two lead clinical programs and other product candidates, to support its collaboration with Children's Hospital of Philadelphia, and for general corporate purposes.

Jefferies LLC served as financial adviser to Aevi Genomic for the transaction and Evercore LLC served as financial adviser to the Children's Hospital of Philadelphia Foundation.